Biosyent Inc (TSXV:RX)
C$ 11.15 0.15 (1.36%) Market Cap: 129.20 Mil Enterprise Value: 112.92 Mil PE Ratio: 18.61 PB Ratio: 3.65 GF Score: 96/100

Biosyent Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript

Dec 07, 2022 / 08:30PM GMT
Release Date Price: C$7.03 (-2.90%)
Robert Kraft
Planet MicroCap - Moderator

Welcome everyone to the Planet MicroCap Showcase Virtual. I'm your host, Robert Kraft. And now presenting at our event is Rene Geohrum. He is the President and CEO of BioSyent. It's publicly traded company. The symbol is RX on the TSX Venture. Rene, take it away.

Rene Geohrum
BioSyent Inc. - President & CEO

Thanks, Bobby. It is a pleasure to be here with you today. I wanted to present BioSyent Inc. We're a Toronto, Ontario, Canada based specialty pharmaceutical company. I just want to draw your viewers and listeners attention to our forward-looking statements disclaimer.

So I'm going to tell you a little bit about BioSyent. As I say, we're based in the Toronto area. We're a profitable growth stage specialty pharmaceutical company. We focus on in-licensing innovative assets that we source around the world, we bring them to the Canadian market, we work them through the regulatory process, and then we commercialize. So, we do all of those commercial functions that you would expect to see in a pharmaceutical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot